Recently we reported that DNA of the human oncogenic papillomaviruses (HPV) and the tumor suppressive human helper virus-dependent parvoviruses, adeno-associated viruses type 2 (AAV-2), colocalize in cervical epithelium. To analyze whether infectious AAV particles are present in cervical tissue, we examined cervical biopsies from 36 patients with HPV-related lesions (squamous intraepithelial lesions) for the presence of AAV DNA and of infectious AAV. From each patient specimens from the lesion and from adjacent normal epithelium were analyzed. After PCR analysis AAV DNA-containing samples were purified by CsCl gradient centrifugation. The presence of AAV virions in CsCl gradients was analyzed and infectivity of AAV was determined. In addition, the biopsies were tested for the presence of HPV DNA. AAV DNA could be detected in biopsies from 23 of 36 patients. AAV particles were found in 11 AAV DNA-positive biopsies from 7 patients (lesions and/or normal tissue, respectively). AAV particles were found to be infectious virions in 10 of the 11 cases. These results demonstrate for the first time that infectious AAV can be isolated from human cervical biopsies, indicating a possible sexual transmission of AAV.
INTRODUCTION
Recent studies have demonstrated the presence of DNA of the human helpervirus-dependent parvovirus (AAV-2) in biopsies of uterus tissues of many women (Tobiasch et al., 1994; Walz et al., 1997; Friedman-Einat et al., 1997) . Together with the detection of AAV DNA in cervical brushings (Han et al., 1996) , these findings suggest a possible sexual transmission of AAV. On the other hand, approximately one-third of all human papillomaviruses (HPV) infect the mucosal epithelium of the anogenital region (Nuovo et al., 1991) and a subset of these, including types 16, 18, 31, 33, and 45 , are associated with over 95% of all cervical cancers (zur Hausen, 1987; zur Hausen, 1991; Gissmann, 1992) .
In contrast to HPV, infection by AAV is negatively associated with cancer development, notably cervical cancer (Mayor et al., 1976) . AAV infection has been reported to inhibit tumor growth of cervix carcinoma cell lines in vivo Su and Wu, 1996) . In addition, AAV has been shown to inhibit oncogenic functions of HPV in vitro (Hermonat, 1994; Hermonat et al., 1997) .
Furthermore, we could show that HPV can provide helper functions for AAV in vitro, inducing replication of AAV DNA and in some cases production of infectious progeny viruses (Walz et al., 1997) . A possible interaction of AAV and HPV also in vivo is suggested by the finding of a coexistence of DNA from both viruses in the same cervical epithelium and in HPV-associated cervical lesions (Walz et al., 1997) , and other`classical'' helper viruses seem to be absent in many AAV-containing tissue samples (Malhomme et al., 1997) .
Colocalization of AAV and HPV in cervical tissue, along with helper functions of HPV for AAV replication may lead to infectious AAV particles in vivo. Therefore, we analyzed cervical biopsies for the presence of AAV virions. Here we report the detection of infectious AAV in biopsies from (HPV-related) squamous intraepithelial lesions (SIL) and from biopsies of normal cervical tissue. These data support the hypothesis that HPV might be a natural helper for AAV in the genital tract and suggest a possible sexual transmission of AAV.
RESULTS

Detection of AAV and HPV DNA in biopsies
We analyzed biopsies from 36 SIL patients for the presence of AAV DNA and virus particles. From 33 patients, in addition to the biopsy from the lesion we also obtained a biopsy from adjacent cervical tissue that showed colposcopically no pathologic changes (normal, N). In total, we analyzed 69 biopsies, from 36 lesions and 33 normal tissues. Material from all lesions had been histologically examined previously and characterized as high-grade SIL. Since AAV DNA has been reported to be present not only in the cervix but also in other human tissues including blood (Grossmann et al., 1992; P. Klein-Bauernschmitt, personal communication, and O. Malhomme, personal communication) we used mouse tissue for control purposes. Tissue samples (e.g., liver) from mice infected systemically with AAV and sacrificed 16 h after infection were analyzed in the same way as the human biopsies. As negative controls, we used biopsies from uninfected mice.
All biopsies were homogenized and AAV-specific PCR analysis of the crude extracts was performed. AAV-positive samples were further analyzed for the presence of AAV particles and the presence of HPV DNA (types 16, 18) by PCR.
Twenty-three of the 36 patients were positive for AAV DNA by PCR analysis of the crude extracts (from N or SIL, see also Fig. 1 ). In 8 of the 23 AAV-positive patients, AAV DNA was found in the lesions (SIL) and was absent in normal tissue. For 7 patients AAV DNA was detected in the lesions and in the normal tissue. Eight patients had AAV DNA in normal tissue but not in the lesion ( Fig. 1 and Table 1 ).
We then analyzed (by PCR) the biopsies from the 23 AAV-infected individuals for the presence of DNA from HPV types 16 and 18. Five SIL biopsies from patients infected with AAV contained HPV 16 DNA and 1 biopsy contained HPV 18 DNA. No HPV DNA was found in biopsies from normal tissue of the AAV DNA-positive SIL patients.
Detection of AAV particles
We further analyzed the AAV DNA-containing biopsies for the presence of AAV particles. Therefore, we performed CsCl density gradient centrifugation on AAV DNA-positive tissue extracts to allow separation of viral particles from free viral DNA. In 11 of 23 AAV DNApositive biopsies AAV DNA was detected by PCR after disruption of particles in fractions with the density corresponding to the density of AAV virions (Fig. 2) .
In 5 AAV DNA-negative biopsies no AAV particles could be detected after CsCl centrifugation (data not shown).
To eliminate false-positive PCR reactions that resulted from free, nonencapsidated AAV DNA contaminating the preparations, we treated CsCl fractions with DNase I In the biopsies (SIL and N) from one patient AAV particles were detected but only the particles retrieved from the N biopsy were infectious (see also Fig. 3 ). after dialysis. To control the DNase I treatment we added AAV DNA and DNase I to negative fractions (see Fig. 2 ).
Two patients had AAV particles in the SIL but not in the adjacent normal tissue. One patient had AAV particles in the normal tissue but no AAV was present in the AAV DNA-containing lesion. In four patients AAV particles were detected in both the lesion and the normal tissue (Table 1) .
In summary, we could detect AAV particles in biopsies from 7 of 23 AAV DNA-positive patients (in a total of 11 biopsies, N and/or SIL).
As mentioned above, we detected HPV 16 DNA in SILs from five patients and HPV 18 DNA in an SIL of one patient. We were able to detect AAV virions in the SILs of three of the five HPV 16-infected and AAV DNA-positive patients.
The liver tissue from the AAV infected mouse but not that from an uninfected animal contained AAV virions as detected by the same method.
AAV virions isolated from human biopsies are infectious
In order to analyze whether the AAV particles detected in the biopsies were infectious, we inoculated positive fractions of the gradients, after treatment with DNase I, on HeLa cell cultures and subsequently superinfected the cultures with adenovirus type 2.
In this assay, only cell cultures inoculated with infectious AAV particles replicate AAV DNA in the presence of adenovirus helper functions. To analyze viral DNA replication, we extracted low-molecular-weight DNA from the cells using the Hirt method and visualized the replicative AAV DNA intermediates by the Southern blot technique. The results demonstrate replication of AAV DNA in cultures inoculated with samples of gradients in 10 of the 11 AAV particle-containing biopsies (Fig. 4) . The particles from one gradient (No. 11) were not infectious or below detection level.
In a further approach we used the`dispersed cell assay'' to analyze infectious virus from the fractions. Three to 4 days after inoculation of HeLa cell cultures with fractions and subsequent adenovirus infection, cells were harvested and the whole cellular DNA was transferred onto a nylon membrane. AAV DNA was visualized by the Southern blot technique with radiolabeled AAV DNA as hybridization probe.
The results showed DNA amplification by replication only in the culture inoculated with AAV-containing fractions from the gradient of biopsy 12 and in the culture incubated with fractions from the liver biopsy of the mouse infected with AAV (Fig. 3) . These results show that samples from an AAV-infected mouse contained sufficient numbers of AAV virions to be detected in this assay and on the other hand show that the biopsy 12 contained Fractions containing AAV particles have a buoyant density of 1.41 to 1.45 g/ml, corresponding to the density of AAV virions. (Density of the fractions is depicted above the autoradiogram.) As indicated (left part of the Southern blot), positive controls were 10 fg and 1 pg of AAV insert DNA. For control of the DNase I we digested 1 pg of AAV DNA with DNase I. As negative control we added DNase I without DNA. As a positive control we performed PCR on virus particles and AAV DNA or particles alone. Furthermore, to avoid residual activity of the DNase I after heat inactivation we added 10 fg of template after inactivation (inakt.) sufficient amounts of AAV to be detected with this assay as well. However, other AAV virion-containing gradients did not show detectable replication in the dispersed cell assay, indicating a very low number of infectious virions in the biopsies.
The results demonstrate that the AAV particles in cervical biopsies from patients with SIL are infectious but are present in very low abundance.
In summary, the cervical tissue of 23 of 36 patients was infected with AAV (AAV DNA detected by PCR). In biopsies from 7 of these 23 AAV-infected patients we could detect AAV particles. In 4 cases particles were found in biopsies from the lesion and in biopsies from normal tissue from the same person; in 2 patients particles were found only in the lesions and in 1 patient only in normal tissue. In conclusion, 11 biopsies contained AAV virions and from these 10 contained infectious AAV. However, 1 biopsy contained AAV particles that were not infectious.
Samples from the crude extracts from the 23 patients infected with AAV were analyzed by PCR for the presence of HPV types 16 and 18. From 23 AAV-infected SIL patients 5 were positive for HPV 16 DNA and 1 for HPV 18 DNA. Three patients who had AAV particles in the SIL were also infected with HPV 16. In the HPV 18-containing lesion no AAV DNA could be detected.
DISCUSSION
We have previously reported, that AAV DNA is frequently present in biopsies of the uterine cervix (Tobiasch et al., 1994) . Recently, these data could be confirmed by analysis of cervical brushings by Han et al. (1996) . Furthermore, we showed that AAV gene expression is detectable in koilocytes (Walz et al., 1997) , which are the typical morphological phenotype of HPV-infected epithelial cells (Meisels et al., 1983) . This demonstrates a close spatial relationship of the two viruses. We could isolate replication-competent AAV DNA from frozen biopsies and even from paraffin-embedded tissue sections, showing that genomic AAV DNA is present in genital tissue (Walz et al., 1997) .
In the present study we analyzed biopsies from women with squamous intraepithelial lesions for the presence of AAV and HPV infection, confirming our earlier reports of the high prevalence of AAV infection in the uterine cervix (Tobiasch et al., 1994; Walz et al., 1997) . Biopsies from 23 of 36 patients were found to contain AAV DNA. We are aware of the possibility of contamination in PCR analyses: Other AAV-infected genital epithelia might be one source of contamination during the extraction of the biopsies; another might be blood, as indicated by the data from Grossman et al. (1992) , even if the frequency of infected blood samples is very low.
However, we describe for the first time the detection of infectious AAV virions in cervical biopsies. As shown by the results from the dispersed cell assay, only a low number of AAV virions is present in the biopsies. It has been shown earlier by in situ hybridization on paraffinembedded samples of cervical tissue that only a very low number of cells contain AAV sequences (Walz et al., 1997) .
The presence of only a few AAV virions in the tissues might be one reason why AAV-related changes like cell lysis, as previously observed in cell culture (Walz et al., 1997) , or tissue destruction were not observed by the histologist. Our findings should incite further studies on possible morphological changes in restricted areas of biopsies or in specific cells, due to AAV and HPV infection.
The presence of AAV virions in cervical biopsies indicates a possible sexual transmission of AAV and further implies that an infection of the cervical epithelium with AAV and a coinfection with HPV could lead to replication of AAV DNA and production of progeny AAV virions.
Experiments are needed to analyze whether in addition AAV integrates its genome into the host cell DNA in the absence of a helper virus or infects cells that carry HPV genomes and start a new round of replication and virion production.
In earlier results from in vitro assays, we showed that HPV 16 is indeed able to provide helper functions for AAV replication in cell culture: Keratinocytes infected with AAV were transfected with HPV DNA, leading to replication of the AAV genomes and AAV virion production (Walz et al., 1997) .
Our present study showed HPV 16 DNA in some of the lesions that carried AAV DNA and in three of these lesions infectious AAV virions were found (see Table 1 ).
These present data showing AAV virions in human cervical biopsies from SIL patients indicate that HPV helper activity might also function in vivo. The presence of other genital HPV types (e.g., types 6, 11, 33) together with AAV in cervical biopsies will have to be determined in further analyses.
Adenovirus has been described as helper for AAV by coinfecting cultured cells of different origin (Carter and Laughlin, 1983; Janik et al., 1981; Laughlin et al., 1982; Richardson and Westphal, 1984) . Other helpers of AAV including herpes simplex virus types I and II (Mishra and Rose, 1990; Weindler and Heilbronn, 1991; Buller et al., 1981) , cytomegalovirus (McPherson et al., 1985) , and vacciniavirus (Schlehofer et al., 1986) were found to provide AAV helper functions in vitro. In recent studies Malhomme et al. (1997) could not detect adenovirus, cytomegalovirus, or herpesvirus coinfection in AAV-containing specimens from the cervix uteri, the endometrium, or abortion material, suggesting that these viruses are possibly less important as helpers for AAV in the genital tract. Therefore, in view of our findings in this study, it is suggestive that HPV may act as a helper for AAV replication and particle production in vivo (Hermonat, 1989; Rabreau and Schlehofer, 1995) . The fact that not only AAV DNA but also infectious AAV virions were detected in cervical biopsies suggests a possible sexual transmission of AAV, perhaps along with the horizontal infection with genital HPV types. Furthermore, this . Fig. 3 ). Only one biopsy (No. 12) contained sufficient AAV virions to yield enough virus to spread within the cell culture to a detectable level. Sample 47 is material from an AAV-infected mouse, sample 48 from an uninfected mouse (internal controls). As control for the helper virus, HeLa cells were infected with serial dilutions (1:10) of adenovirus (leftmost row of wells, ϩ indicating wells with visible CPE after 3 days.
FIG. 4. Dot blot analysis of adenovirus-infected HeLa cells, inoculated with biopsy fractions (cf
implies that AAV could subsequently infect cells of the endometrium and even embryonal tissues, as has been reported elsewhere (Tobiasch et al., 1994; Malhomme et al., 1997) .
The role of certain HPV types in the causation of anogenital lesions and cancer of the uterine cervix is well established (Gissmann, 1992; zur Hausen, 1987 zur Hausen, , 1991 . A subset of these HPV types, including types 16, 18, 31, 33, and 45, are associated with over 95% of all cervical cancers (Bosch et al., 1995; Matsukura and Sugase, 1995) .
It has been reported that AAV infection interferes with tumor development (for review, cf. Schlehofer, 1994) . Most interesting are results from seroepidemiologic studies showing that cervical cancer patients exhibit antibodies to AAV less frequently than healthy control individuals (Mayor et al., 1976; Georg-Fries et al., 1984; Sprecher-Goldberger et al., 1971) . Several studies showed that AAV infection inhibits cellular transformation by BPV-1 and HPV 16 (Hermonat, 1989 (Hermonat, , 1994 (Hermonat, , 1992 Hermonat et al., 1997) as well as HPV 18 (Ho Èrer et al., 1995) . Some of these effects could be shown to be mediated by the AAV Rep 78 protein (Hermonat, 1992; Hermonat et al., 1997) down-regulating the expression of the papillomavirus oncogenes. In addition, it could be shown that Rep 78 is also able to inhibit the expression of heterologous genes like c-Ha-ras or the HIV long terminal repeats (Katz and Carter, 1986; Ho Èrer et al., 1995; Hermonat, 1991; Hermonat et al., 1996 Hermonat et al., , 1997 Rittner et al., 1992) . Furthermore, a recent report showed that AAV Rep 78 interacts with the cellular transcription factor SP1, thus down-regulating SP1-mediated promoter activity .
We speculate that coinfection of cells in the cervical epithelium with specific HPV types and AAV may lead to AAV replication and AAV virus production and probably to a cytopathic effect and cell death, as we have shown for HPV type 16 (Walz et al., 1997) . Other types, including HPV 33, 11, and 6, that also infect the cervical epithelium still have to be analyzed for their interaction with AAV.
In the absence of helpers, infection with AAV probably results in integration of AAV genomes into the cellular DNA, as suggested by in vitro studies (Kotin et al., 1990; Samulski et al., 1991; . Persistent AAV infection could be reactivated (rescue) by subsequent infection with HPV, leading to progeny AAV production and possibly to lysis of HPV-infected cells. This may preclude malignant transformation of the respective cells.
The explanation for the presence of AAV in SILs which are premalignant lesions induced by HPV might be the fact that not all cells have been infected by AAV. It is still not known if other than epithelial cells of the cervix are persistantly infected by AAV in the genital tract and further analyses including AAV-and HPV-specific in situ hybridization and immunohistochemistry are needed to show individual cells that are coinfected with both viruses and are replicating AAV DNA.
It seems of great importance to investigate the further progress of the SIL in each individual patient. This might show whether lesions of AAV-infected patients tend to regress at a higher frequency than those of uninfected patients.
MATERIAL AND METHODS
Cell culture
Cells of the cervical carcinoma cell line HeLa and HeLa-derived cells containing integrated AAV-2 DNA (HA 16, were cultivated in Eagle's minimal essential medium (Dulbecco modification, D-MEM, GIBCO, Bethesda, MD) supplemented with 10% fetal calf serum (FCS, GIBCO) and penicillin/streptomycin (100 u/ml/100 g/ml), at 37°C, 5% CO 2 , in a humidified atmosphere.
Virus
Adeno-associated virus type 2 (AAV-2) was propagated in HeLa cells by coinfection with adenovirus type 2 (Ad-2), purified, and titrated as described previously (Yacobson et al., 1987; . Adenovirus type 2 was purchased from ATCC (Rockville, MD).
Plasmids
The genomic AAV DNA insert of the plasmid pTAV2 (Heilbronn et al., 1990) was used for radiolabeled probes and for PCR controls. For HPV 16 probe, we used the complete viral genomic DNA, excised from the vector by cleaving with BamHI restriction enzyme (Du Èrst et al., 1983) . For hybridization, DNA radiolabeling was performed with [␣- 32 P]dCTP (Amersham, Arlington Heights, IL) using the random priming technique (Feinberg and Vogelstein, 1996) .
Biopsies
From 36 patients, specimens from squamous intraepithelial lesions (SIL, Anonymous, 1988) and from adjacent normal epithelium were frozen in liquid nitrogen after extraction. From 3 patients, only biopsies from the lesion were available. Material from all samples was pathologically characterized. The biopsies were about 1±3 mm 3 in size. As positive controls for AAV-containing samples, we used liver biopsies from AAV-infected mice 16 h postinfection (since in previous analyses with AAV-infected mice we had shown that AAV DNA could be detected in blood samples up to 2 days after intravenous infection .
PCR
As negative controls in PCR analyses, tissue biopsies from uninfected mice were used. All biopsies were han-dled separately in an AAV-and HPV-free sterile work bench. If possible, we used disposable material for treatment of biopsies; all other materials (e.g., glass homogenizers) were washed with 36% HCl and 5% SDS, rinsed with 100% ethanol, and finally autoclaved to avoid cross contamination.
For detection of AAV 2 DNA, the following primers were used (Han et al., 1996) : AAV-2: No. 1Ð5ЈCAT CGC GGA GGC CAT AGC CC-3Ј (nt 1346 to 1365); No. 2Ð5Ј-ACG GGA GTC GGG TCT ATC TG-3Ј (nt 1567 to 1548). For amplification, we used a Perkin±Elmer GeneAmp 2400 programmed for 1 cycle at 95°C for 5 min, 35 cycles of 40 s at 94°C, 40 s at 63°C, and 30 s at 75°C and a final cycle for 10 min at 75°C. Amplification resulted in a product of 221 bp. As positive controls of the PCR, we used 10 fg and 1 pg of AAV DNA (pTAV2, cf. above).
HPV-specific primers were used according to van den Brule et al. (1990) For amplification we performed 1 cycle at 95°C for 4 min, 30 cycles of 1 min at 95°C, 2 min at 55°C, and 1 min 30 s at 72°C, and 1 cycle at 72°C for 5 min. As positive control of the PCR reaction, we used 10 fg of genomic HPV DNA of the respective types.
As negative control for each PCR reaction we used the PCR reaction mix containing the respective primers lacking template DNA. PCR products were separated by electrophoresis on a 1% agarose gel, transferred to a Nylon membrane by the Southern blot technique, and immobilized by UV crosslinking. Blots were hybridized with radiolabeled genomic AAV or radiolabeled HPV DNA and exposed to X-ray film.
Virion extraction from biopsies
Biopsies were cut into small pieces and incubated at 37°C for 30 min in 10 ml of 140 mM NaCl, 5 mM KCl, 0.7 mM K 2 HPO 4 , 25 mM Tris±HCl, pH 7.4, after adding 500 l 10% sodium deoxycholate. Thereafter, the lysates were homogenized with a glass homogenizer type A (20 strokes), and 5 l of the homogenate was boiled for 10 min and tested using AAV PCR as described below. AAV-containing lysates were further analyzed for the presence of HPV DNA by PCR.
CsCl (6.5 g) was added to 10 ml homogenate of the AAV DNA-positive samples (PCR) and five representative AAV DNA-negative samples for control purposes. After dissolving of the cell homogenate, the refraction index was determined and adjusted to 1.372 OD.
Ultracentrifugation was performed at 38,000 rpm at 20°C for 26 h in a TH641 (Sorvall) swinging bucket rotor.
The gradients were fractionated (about 200±300 l per fraction) from the bottom using a syringe needle. Density of the fractions was measured using a refractometer (AAV particles band at a CsCl density of 1.40 g/ml, HPV at 1.32 g/ml) (Cukor et al., 1984; Crawford and Crawford, 1993) . The fractions were dialyzed against PBS (or 1 M NaCl) at room temperature for 30 min. To avoid contamination with nonencapsidated AAV DNA in the samples, dialyzed aliquots of the fractions were treated with RNase-free DNase I (Boehringer, Mannheim Germany) prior to PCR [10 l dialyzed fraction sample, 5 l MgCl 2 (25 mM) and 20 u of DNase in a final volume of 50 l] overnight at room temperature. To inactivate DNase and to release the viral DNA from the capsids, samples were boiled for 15 min. Five microliters of each fraction was then used for HPV and AAV 2-specific PCR, respectively.
Identification of infectious AAV virions
The presence of infectious AAV particles was tested in a standard cell culture assay using adenovirus 2 (Ad-2) as a helper for AAV replication. Dialyzed samples of the gradients were incubated with HeLa cells for 45 min at 37°C. Cultures were then infected with Ad-2 (m.o.i. ϭ 1 PFU per cell) and again incubated for 30 min at 37°C. Finally, medium was added and the cells were cultured until a complete cytopathic effect of the adenovirus was visible. The cultures were subjected to three freeze and thaw cycles and replication of infectious virus in the inoculum was visualized by analysis of AAV DNA amplification.
Hirt extraction. To analyze the viral DNA replication we used the cell culture assay described above. When the complete cytopathic effect of Ad-2 was visible, cultures were harvested and centrifuged at 500 g for 15 min. The cell-free supernatant was transferred onto subconfluent HeLa cells in 35-mm dishes and cultured for 24 h. Culture samples were washed twice with PBS and lowmolecular-weight DNA was extracted according to Hirt (1967) . Ten micrograms of low-molecular-weight DNA was separated by agarose gel electrophoresis and transferred onto Nylon membranes. Immobilized DNA was hybridized with radiolabeled AAV-2 DNA and exposed to X-ray films. As a molecular size marker we used DNA digested with HindIII. As a negative control for the Southern blot we applied DNA from HeLa cells digested with EcoRV. As a positive control low-molecular-weight DNA from either adenovirus-infected HA 16 cells (persistently AAV-infected HeLa cells) or from HeLa cells coinfected with AAV and adenovirus was used. DNA from HeLa cells infected with adenovirus was used as control for a possible contamination of the adenovirus stock with AAV.
Dispersed cell assay. After freeze±thawing of cultures, inoculated as described above, samples were transferred onto a nylon membrane by suction. Replication of AAV DNA was measured by hybridization with a radiolabeled AAV probe. Signals on the film indicated amplification of viral DNA, thus showing the presence of infectious AAV particles in the fractions inoculated onto cells. Infection of HeLa cells by adenovirus alone was used as a negative control, with AAV of known titer plus adenovirus coinfection as a positive control. 
